Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Diabetes & Metabolism Journal|March 15, 2014
Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth korean national health and nutrition examination survey in 2011Seung-Hyun Ko, Hyuk-Sang Kwon, Dae Jung Kim, et al.
Diabetes & Metabolism Journal|July 9, 2014
Current status of glycemic control of patients with diabetes in Korea: the fifth Korea national health and nutrition examination surveyJa Young Jeon, Dae Jung Kim, Seung-Hyun Ko, et al.
Diabetology & Metabolic Syndrome|August 25, 2015
Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter studySeung Jin Han, Hae Jin Kim, Dae Jung Kim, et al.
Korean Diabetes Journal|July 10, 2010
Is A1C Variability an Independent Predictor for the Progression of Atherosclerosis in Type 2 Diabetic Patients?Chul Sik Kim, So Young Park, Sung Hoon Yu, et al.
Diabetes & Metabolism Journal|May 23, 2014
Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination surveyJae Hee Ahn, Ji Hee Yu, Seung-Hyun Ko, et al.
Diabetes & Metabolism Journal|November 8, 2013
Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1cJa Young Jeon, Seung-Hyun Ko, Hyuk-Sang Kwon, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|April 17, 2019
The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitusHae Jin Kim, So-Yeon An, Seung Jin Han, et al.
Medicine|November 28, 2023
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III studySeung-Ah Lee, Soon Jun Hong, Jung-Hoon Sung, et al.
Diabetes & Metabolism|March 11, 2023
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D studyKyung-Soo Kim, Kyung Ah Han, Tae Nyun Kim, et al.
Pageof 8